Published in BMC Ophthalmol on December 08, 2014
Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res (2016) 0.85
Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration? Autoimmun Rev (2017) 0.76
Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration. Clin Ophthalmol (2017) 0.75
Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders. Front Immunol (2017) 0.75
A Novel Brucine Gel Transdermal Delivery System Designed for Anti-Inflammatory and Analgesic Activities. Int J Mol Sci (2017) 0.75
Risk factors associated with age-related macular degeneration. A case-control study in the age-related eye disease study: Age-Related Eye Disease Study Report Number 3. Ophthalmology (2000) 5.18
Risk factors for age-related macular degeneration: Pooled findings from three continents. Ophthalmology (2001) 5.06
Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases. Ann Rheum Dis (2003) 4.36
Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med (2008) 3.92
The role of inflammation in the pathogenesis of age-related macular degeneration. Surv Ophthalmol (2006) 3.60
Multifaceted roles of glycolytic enzymes. Trends Biochem Sci (2005) 3.01
Immunological and aetiological aspects of macular degeneration. Prog Retin Eye Res (2001) 2.87
Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun (2009) 2.49
Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat Genet (2009) 2.48
Carboxyethylpyrrole protein adducts and autoantibodies, biomarkers for age-related macular degeneration. J Biol Chem (2003) 2.30
A look at autoimmunity and inflammation in the eye. J Clin Invest (2010) 2.30
Risk factors for age-related macular degeneration. Prog Retin Eye Res (2001) 2.22
Autoimmune retinopathy: a review and summary. Semin Immunopathol (2008) 2.16
Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol (2004) 1.83
Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev (2009) 1.68
Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev (2006) 1.66
Cigarette smoking and inflammation: cellular and molecular mechanisms. J Dent Res (2011) 1.62
The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol (1996) 1.54
Age-related macular degeneration and the immune response: implications for therapy. Am J Ophthalmol (2007) 1.49
α-Enolase, a multifunctional protein: its role on pathophysiological situations. J Biomed Biotechnol (2012) 1.48
Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47
Age related macular degeneration and drusen: neuroinflammation in the retina. Prog Neurobiol (2011) 1.44
Assessing susceptibility to age-related macular degeneration with proteomic and genomic biomarkers. Mol Cell Proteomics (2009) 1.39
Complement in age-related macular degeneration: a focus on function. Eye (Lond) (2011) 1.39
Bruch's membrane and choroidal macrophages in early and advanced age-related macular degeneration. Br J Ophthalmol (2009) 1.37
Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp Eye Res (2006) 1.36
Aging is not a disease: distinguishing age-related macular degeneration from aging. Prog Retin Eye Res (2013) 1.29
Anti-enolase-alpha autoantibodies in cancer-associated retinopathy: epitope mapping and cytotoxicity on retinal cells. J Autoimmun (1998) 1.28
Inflammation and age-related macular degeneration (AMD). Semin Ophthalmol (2011) 1.22
CCL2/CCR2 and CX3CL1/CX3CR1 chemokine axes and their possible involvement in age-related macular degeneration. J Neuroinflammation (2010) 1.18
Markers of inflammation, oxidative stress, and endothelial dysfunction and the 20-year cumulative incidence of early age-related macular degeneration: the Beaver Dam Eye Study. JAMA Ophthalmol (2014) 1.17
The role of the immune response in age-related macular degeneration. Int J Inflam (2013) 1.16
Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism. J Neurochem (2009) 1.12
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration. Immunology (2005) 1.08
Gender differences in autoantibodies to oxidative DNA base damage in cigarette smokers. Cancer Epidemiol Biomarkers Prev (2001) 1.05
Age-related macular degeneration: genetic and clinical findings. Clin Chem Lab Med (2010) 1.04
Cellular targets of anti-alpha-enolase autoantibodies of patients with autoimmune retinopathy. J Autoimmun (2004) 1.04
Autoimmunity in retinal degeneration: autoimmune retinopathy and age-related macular degeneration. J Autoimmun (2009) 1.01
Identification of anti-retinal antibodies in patients with age-related macular degeneration. Exp Mol Pathol (2012) 0.98
Serum autoantibody biomarkers for age-related macular degeneration and possible regulators of neovascularization. Exp Mol Pathol (2011) 0.97
Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int Rev Immunol (2002) 0.95
Insights into endocrine-immunological disturbances in autoimmunity and their impact on treatment. Arthritis Res Ther (2009) 0.95
Association between testosterone levels and risk of future rheumatoid arthritis in men: a population-based case-control study. Ann Rheum Dis (2013) 0.94
Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol (2006) 0.93
CEP biomarkers as potential tools for monitoring therapeutics. PLoS One (2013) 0.92
Inverse relationship between total testosterone and anti-oxidized low density lipoprotein antibody levels in ageing males. Atherosclerosis (2002) 0.89
Chemokine receptor expression in peripheral blood monocytes from patients with neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci (2012) 0.88
Complement factor h autoantibodies and age-related macular degeneration. Invest Ophthalmol Vis Sci (2010) 0.87
Interphotoreceptor retinoid-binding protein (IRBP) in progressive rod-cone degeneration (prcd)--biochemical, immunocytochemical and immunologic studies. Exp Eye Res (1991) 0.87
CRALBP is a highly prevalent autoantigen for human autoimmune uveitis. Clin Dev Immunol (2007) 0.86
Significance of Anti-retinal Autoantibodies in Cancer-associated Retinopathy with Gynecological Cancers. J Clin Exp Ophthalmol (2013) 0.86
Autoimmunity and T-cell subpopulations in old age. Arch Gerontol Geriatr (1988) 0.85
Retinal autoantibody profile in early age-related macular degeneration: preliminary findings from the Blue Mountains Eye Study. Clin Experiment Ophthalmol (2006) 0.84
CRALBP transcriptional regulation in ciliary epithelial, retinal Müller and retinal pigment epithelial cells. Exp Eye Res (2003) 0.82
Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. J Neuroimmunol (2012) 0.82
Anti-retinal antibodies in patients with macular telangiectasia type 2. Invest Ophthalmol Vis Sci (2013) 0.81
Retinitis pigmentosa, Coats disease and uveitis. Eur J Ophthalmol (1999) 0.79
Circulating antiretinal antibodies predict the outcome of anti-VEGF therapy in patients with exudative age-related macular degeneration. Acta Ophthalmol (2011) 0.78
Complement factor H polymorphism in age-related macular degeneration. Science (2005) 31.10
Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results. Ophthalmology (2012) 11.91
Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med (2010) 10.75
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2010) 10.28
A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol. Am J Ophthalmol (2003) 9.99
Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology (2003) 8.98
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
von Hippel-Lindau disease. Lancet (2003) 6.20
Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. N Engl J Med (2008) 4.46
The Age-Related Eye Disease Study severity scale for age-related macular degeneration: AREDS Report No. 17. Arch Ophthalmol (2005) 4.46
Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration. Proc Natl Acad Sci U S A (2010) 4.30
Association between C-reactive protein and age-related macular degeneration. JAMA (2004) 4.16
Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema. Ophthalmology (2011) 4.15
Seven new loci associated with age-related macular degeneration. Nat Genet (2013) 3.81
A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. Arch Ophthalmol (2005) 3.74
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation (2008) 3.63
Age-related macular degeneration. Lancet (2008) 3.34
Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. JAMA (2007) 3.34
Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19. Ophthalmology (2005) 3.28
Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol (2009) 3.21
Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. Arch Ophthalmol (2003) 3.17
Prevalence of refractive error in the United States, 1999-2004. Arch Ophthalmol (2008) 3.06
The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog Retin Eye Res (2005) 3.03
The relationship of dietary carotenoid and vitamin A, E, and C intake with age-related macular degeneration in a case-control study: AREDS Report No. 22. Arch Ophthalmol (2007) 3.02
Age-related macular degeneration--a genome scan in extended families. Am J Hum Genet (2003) 2.99
Panretinal photocoagulation for proliferative diabetic retinopathy. N Engl J Med (2011) 2.98
Diabetic retinopathy. Diabetes Care (2004) 2.97
Pharmacogenetics for genes associated with age-related macular degeneration in the Comparison of AMD Treatments Trials (CATT). Ophthalmology (2013) 2.82
Analysis of the ARMD1 locus: evidence that a mutation in HEMICENTIN-1 is associated with age-related macular degeneration in a large family. Hum Mol Genet (2003) 2.72
Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology (2007) 2.69
Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results. Ophthalmology (2012) 2.68
Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial. Hum Gene Ther (2006) 2.59
Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci U S A (2010) 2.43
Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. Annu Rev Genomics Hum Genet (2009) 2.40
Meta-analysis of genome scans of age-related macular degeneration. Hum Mol Genet (2005) 2.34
Fundus autofluorescence imaging of the white dot syndromes. Arch Ophthalmol (2010) 2.26
The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS Report No. 20. Arch Ophthalmol (2007) 2.12
Self-assembly and properties of diblock copolymers by coarse-grain molecular dynamics. Nat Mater (2004) 2.07
The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age-related macular degeneration. FASEB J (2004) 2.04
De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci U S A (2002) 1.95
The relationship of dietary omega-3 long-chain polyunsaturated fatty acid intake with incident age-related macular degeneration: AREDS report no. 23. Arch Ophthalmol (2008) 1.93
Molecular dynamics calculations suggest a conduction mechanism for the M2 proton channel from influenza A virus. Proc Natl Acad Sci U S A (2009) 1.93
Serum inflammatory markers in diabetic retinopathy. Invest Ophthalmol Vis Sci (2005) 1.92
Folic acid, pyridoxine, and cyanocobalamin combination treatment and age-related macular degeneration in women: the Women's Antioxidant and Folic Acid Cardiovascular Study. Arch Intern Med (2009) 1.83
Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci (2008) 1.83
Risk assessment model for development of advanced age-related macular degeneration. Arch Ophthalmol (2011) 1.75
Functional studies and modeling of pore-lining residue mutants of the influenza a virus M2 ion channel. Biochemistry (2010) 1.73
An emerging consensus on voltage-dependent gating from computational modeling and molecular dynamics simulations. J Gen Physiol (2012) 1.72
Risk of advanced age-related macular degeneration after cataract surgery in the Age-Related Eye Disease Study: AREDS report 25. Ophthalmology (2008) 1.69
Lack of association between thiazolidinediones and macular edema in type 2 diabetes: the ACCORD eye substudy. Arch Ophthalmol (2010) 1.68
Tachyphylaxis after intravitreal bevacizumab for exudative age-related macular degeneration. Retina (2009) 1.67
The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology (2012) 1.66
Probing the structure of DNA-carbon nanotube hybrids with molecular dynamics. Nano Lett (2007) 1.65
A novel diagnostic test detects a low frequency of the hemicentin Gln5345Arg variant among Northern Irish age related macular degeneration patients. Mol Vis (2004) 1.64
Blindness and visual impairment: a public health issue for the future as well as today. Arch Ophthalmol (2004) 1.63
Understanding nature's design for a nanosyringe. Proc Natl Acad Sci U S A (2004) 1.62
CFH gene variant, Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration. Hum Hered (2006) 1.62
Low-dose aspirin and medical record-confirmed age-related macular degeneration in a randomized trial of women. Ophthalmology (2009) 1.62
Shrinkage of a rapidly growing tumor by drug-loaded polymersomes: pH-triggered release through copolymer degradation. Mol Pharm (2006) 1.61
Embedded cholesterol in the nicotinic acetylcholine receptor. Proc Natl Acad Sci U S A (2008) 1.61
National Eye Institute Visual Function Questionnaire in the Age-Related Eye Disease Study (AREDS): AREDS Report No. 10. Arch Ophthalmol (2003) 1.61
Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology (2008) 1.60
Retinal precursors and the development of geographic atrophy in age-related macular degeneration. Ophthalmology (2007) 1.59
Discrimination of methylcytosine from hydroxymethylcytosine in DNA molecules. J Am Chem Soc (2010) 1.59
Self-assembly of Janus dendrimers into uniform dendrimersomes and other complex architectures. Science (2010) 1.59
Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci (2008) 1.58
Computer simulation studies of model biological membranes. Acc Chem Res (2002) 1.56
Change in area of geographic atrophy in the Age-Related Eye Disease Study: AREDS report number 26. Arch Ophthalmol (2009) 1.53
Rationale for the diabetic retinopathy clinical research network treatment protocol for center-involved diabetic macular edema. Ophthalmology (2011) 1.52
Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. Proc Natl Acad Sci U S A (2006) 1.52
De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications. Acc Chem Res (2010) 1.52
Prevalence of posterior subcapsular cataracts in volunteer cytapheresis donors. Transfusion (2010) 1.51
Intermediate states of the Kv1.2 voltage sensor from atomistic molecular dynamics simulations. Proc Natl Acad Sci U S A (2011) 1.49
Unfolding a linker between helical repeats. J Mol Biol (2005) 1.48
An electronic medical records system for clinical research and the EMR EDC interface. Invest Ophthalmol Vis Sci (2007) 1.48
Complement component C5a promotes expression of IL-22 and IL-17 from human T cells and its implication in age-related macular degeneration. J Transl Med (2011) 1.47
Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina. Retina (2007) 1.46
{omega}-3 Long-chain polyunsaturated fatty acid intake and 12-y incidence of neovascular age-related macular degeneration and central geographic atrophy: AREDS report 30, a prospective cohort study from the Age-Related Eye Disease Study. Am J Clin Nutr (2009) 1.44
Macular telangiectasia type 2. Prog Retin Eye Res (2012) 1.44
Does long-term aspirin use increase the risk of neovascular age-related macular degeneration? Expert Opin Drug Saf (2014) 1.41
Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration. Arch Ophthalmol (2005) 1.40
Identification of a rare coding variant in complement 3 associated with age-related macular degeneration. Nat Genet (2013) 1.39
Molecular dynamics simulation directed rational design of inhibitors targeting drug-resistant mutants of influenza A virus M2. J Am Chem Soc (2011) 1.37
Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr (2006) 1.35
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care (2005) 1.34